The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology
Open accessAbstract
We hypothesize that microglial chemotactic responses to amyloid-β peptide (Aβ 1–42) serve as an early and integral component of inflammatory response in Alzheimer's disease (AD) brain. This study reports a receptor for vascular endothelial growth factor (VEGF), termed VEGF-1 (Flt-1), subserves microglial chemotactic responses induced by Aβ 1–42 stimulation,in vivo and in vitro. Expression of Flt-1 was significantly increased in tissue obtained from AD patients [compared with tissue from nondemented (ND) individuals], in Aβ 1–42-injected rat hippocampus, and in peptide-stimulated human microglia. Single and double immunohistochemical staining demonstrated marked immunoreactivity, for both Flt-1 and its ligand VEGF, in association with microglia and Aβ deposits in AD, but not ND, brain tissue. Functionally, treatment with anti-Flt-1 antibody was highly effective in inhibiting microglial mobility and chemotactic responses measured in vitro using a transwell migration assay.In vivo, transplanted enhanced green fluorescent protein (EGFP)-labeled microglia exhibited Flt-1-dependent chemotaxis induced by peptide injection with anti-Flt-1 effective in blocking migration of cells. Importantly, anti-Flt-1 reduction of microglial mobility was neuroprotective in peptide-injected hippocampus and associated with a significant increase in numbers of viable hippocampal neurons. The results of this study suggest critical functional roles for Flt-1 in mediating microglial chemotactic inflammatory responses which contribute to pathological conditions in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, upregulation of Flt-1 has been observed in the entorhinal cortical sections from human AD brain and in human microglia cells following treatment with Aβ42.36”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [36]
In the citing paper
“The growth factor VEGF, along with its receptor Flt-1, which is expressed on microglia, has also been implicated in the microglial chemotactic response to Aβ deposits through both in vitro and in vivo experiments [86].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marmé, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,350
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Corneal avascularity is due to soluble VEGF receptor-1
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R., Richter, E. R., Sakurai, E., Newcomb, M. T., et al. (2006) · Nature · doi:10.1038/nature05249 · Cited by 703
Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 2×
“Microglial VEGF Receptor Response Is an Integral”
BackgroundMicrovascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487
Migration and differentiation of neural precursor cells can be directed by microglia
Aarum, J., Sandberg, K., Haeberlein, S. L. B., & Persson, M. A. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237050100 · Cited by 450
Hoshino, M., Takahashi, M., & Aoike, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.111928 · Cited by 420
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R. E., Brigham, E. F., Yang, L., Hampel, H. J., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 392
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360
Glial cell influence on the human blood‐brain barrier
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 334
Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00994.x · Cited by 307
McLarnon, J. G., Ryu, J. K., Walker, D. G., & Choi, H. B. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240470.97295.d3 · Cited by 281
Self-citationAlzheimer's disease and angiogenesis
Vagnucci, A. H., & Li, W. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12521-4 · Cited by 267
Guo, J., Arai, T., Miklossy, J., & McGeer, P. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509386103 · Cited by 260
Complement and cytokine gene expression in cultured microglia derived from postmortem human brains
Walker, D. G., Kim, S. U., & McGeer, P. L. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400407 · Cited by 248
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Alzheimer's disease and angiogenesis
Agorogiannis, E. I., & Agorogiannis, G. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13000-0 · Cited by 224
Arai, T., Judith Miklossy, A., Klegeris, A., Guo, J., & McGeer, P. L. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000196133.74087.cb · Cited by 189
Walker, D. G., Link, J., Lue, L., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 183
Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells
Forstreuter, F., Lucius, R., & Mentlein, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00315-6 · Cited by 178
Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 176
Ryu, J. K., Kim, J., Cho, S. J., Hatori, K., Nagai, A., Choi, H. B., Lee, M. C., McLarnon, J. G., & Kim, S. U. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.016 · Cited by 175
Self-citationChoi, H. B., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5417-06.2007 · Cited by 173
Self-citationVEGF and VEGF Receptor Expression after Experimental Brain Contusion in Rat
Sköld, M. K., von Gertten, C., Sandberg-Nordqvist, A.-C., Mathiesen, T. I., & Holmin, S. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.353 · Cited by 142
Bandt, M. D., Mahdi, M. H. B., Ollivier, V., Grossin, M., Dupuis, M., Gaudry, M., Böhlen, P., Lipson, K. E., Rice, A. G., Wu, Y. L., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4853 · Cited by 122
A Survey of Practice Patterns in Concussion Assessment and Management.
Ferrara, M. S., McCrea, M., Peterson, C. L., & Guskiewicz, K. M. (2001) · PubMed Central · Cited by 93
Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503e1 · Cited by 86
Ryu, J. K., & McLarnon, J. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.019 · Cited by 85
Self-citationRyu, J. K., Choi, H. B., & McLarnon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 83
Self-citationPerturbations in calcium‐mediated signal transduction in microglia from Alzheimer's disease patients
McLarnon, J. G., Choi, H. B., Lue, L., Walker, D. G., & Kim, S. U. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20487 · Cited by 73
Self-citationFranciosi, S., Ryu, J. K., Choi, H. B., Radov, L. A., Kim, S. U., & McLarnon, J. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2490-06.2006 · Cited by 69
Self-citationYang, M.-S., Ji, K., Jeon, S., Jin, B.-K., Kim, S. U., Jou, I., & Joe, E.-H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1323 · Cited by 68
Ryu, J. K., & McLarnon, J. G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.016 · Cited by 66
Self-citationAngiogenic signaling in Alzheimer's disease
Pogue, A. I., & Lukiw, W. J. (2004) · Neuroreport · doi:10.1097/01.wnr.0000130539.39937.1d · Cited by 65
Feistritzer, C., Kaneider, N. C., Sturn, D. H., Mosheimer, B. A., Kähler, C. M., & Wiedermann, C. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0314oc · Cited by 56
Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients
Lue, L., Brachova, L., Walker, D. G., & Rogers, J. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00006-1 · Cited by 55
Casolini, P., Domenici, M. R., Cinque, C., Alemà, G., Chiodi, V., Galluzzo, M., Musumeci, M., Mairesse, J., Zuena, A. R., Matteucci, P., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1074-07.2007 · Cited by 39
Judith Miklossy, A., Qing, H., Guo, J.-P., Yu, S. Y., Wszołek, Z. K., Calne, D. B., McGeer, E. G., & McGeer, P. L. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0230-9 · Cited by 23
Hashemzadeh‐Bonehi, L., Phillips, R., Cairns, N. J., Mosaheb, S., & Thorpe, J. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.030 · Cited by 20
Lentiviral vector–mediated, in vivo gene transfer to the tracheobronchial tree in fetal rabbits
Skarsgard, E. D., Huang, L., Reebye, S. C., Yeung, A. Y., & Jia, W. W.-G. (2005) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2005.08.047 · Cited by 16
Induction of angiogenesis by platelet-activating factor in the rat striatum
Tran, K., Ryu, J., & McLarnon, J. (2005) · NeuroReport · doi:10.1097/01.wnr.0000179073.24412.7b · Cited by 10
Self-citation
Cited by
Sorted by citations
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 570
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 471
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000006082 · Cited by 359
Metadata
- Authors
- Ryu, J. K., Cho, T., Choi, H. B., Wang, Y. T., & McLarnon, J. G.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McLarnon, James G.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-01-07
- Volume
- 29
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6664925
- OpenAlex
- W2022811766
- Cited by
- 121
- References
- 45
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 12 · 2023: 10 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 1 · 2015: 9 · 2014: 6 · 2013: 13 · 2012: 8
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Fondation pour la Recherche sur Alzheimer
- Department of Psychiatry, Faculty of Medicine, University of British Columbia
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microglia, amyloid-beta, microglial chemotaxis, neuroinflammation, microglial migration, neuroprotection, hippocampus, amyloid-beta deposition
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Analysis of Variance, Animals, Cell Movement, Cells, Cultured, Disease Models, Animal, Glial Fibrillary Acidic Protein, Hippocampus, HLA-DR Antigens, Humans, Mice, Transgenic, Middle Aged, Peptide Fragments, Phosphopyruvate Hydratase, Postmortem Changes, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Microglia, Entorhinal Cortex, CD11b Antigen, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review